The Rokita Lab

Testbed

Basic formatting

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

External link

Internal link

italic text

bold text

strike-through text



Text with extra blank lines above and below

  1. ordered list item 1
  2. ordered list item 2
  3. ordered list item 3
  1. top level list item
    • nested list item
      1. even deeper nested list item

Plain image:

plain image

Heading 1

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Heading 2

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Heading 3

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Heading 4

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Heading 5

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Heading 6

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.


TABLE Game 1 Game 2 Game 3 Total
Anna 144 123 218 485
Bill 90 175 120 385
Cara 102 214 233 549

It was the best of times it was the worst of times. It was the age of wisdom, it was the age of foolishness. It was the spring of hope, it was the winter of despair.

// some code with syntax highlighting
const popup = document.querySelector("#popup");
popup.style.width = "100%";
popup.innerText =
  "Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.";

This sentence has inline code, useful for making references to variables, packages, versions, etc. within a sentence.

Lorem ipsum dolor sit amet.

Consectetur adipiscing elit.

Sed do eiusmod tempor incididunt.

Hidden content

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Jekyll Spaceship

Stage Direct Products ATP Yields
Glycolysis
2 ATP  
2 NADH 3–5 ATP
Pyruvaye oxidation 2 NADH 5 ATP
Citric acid cycle

2 ATP  
6 NADH 15 ATP
2 FADH 3 ATP
30–32 ATP    

$ a * b = c ^ b $

$ 2^{\frac{n-1}{3}} $

$ \int_a^b f(x)\,dx. $

Components

Section

Section, background

Section, dark=true

Section, background dark=true

Section, size=wide

Section, size=full w/ figure

figure image

Figure

figure image
Lorem ipsum .
Lorem ipsum.
Lorem ipsum . px width
Lorem ipsum. px width
Lorem ipsum . width
Lorem ipsum. % width
Lorem ipsum . px height
Lorem ipsum. px height
Lorem ipsum . px width, svg
Lorem ipsum. px width, svg
Lorem ipsum . width, svg
Lorem ipsum. % width, svg
Lorem ipsum . px height, svg
Lorem ipsum. px height, svg

Button

Icon

Lorem Ipsum Dolor

Feature

Title

Title

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Title

Title

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

List

List citations

2026

The Common Fund Data Ecosystem
Julie A. Jurgens, Andreas Bueckle, Jeet Vora, Mano R. Maurya, Taha Mohseni Ahooyi, …, Kelli Bursey, Avi Ma’ayan, Raja Mazumder, Matthew E. Roth, Casey S. Greene
Patterns  ·  01 Nov 2026  ·  doi:10.1016/j.patter.2026.101714
TAPESTRY: an interactive resource for exploring tumor-enriched splice junctions in pediatric brain tumors
Patricia J. Sullivan, Ryan J. Corbett, Chao Di, Alex Sickler, Aylar Babaei, Meghali Goswami, Jo Lynne Rokita
arXiv  ·  26 Oct 2026  ·  arxiv:2610.31816
Pan-pediatric brain tumor microRNA networks define immune microenvironment states and responses to CAR T-cell therapy
Kaleem Coleman, Ryan J Corbett, Zhongzhen Yi, Bicna Song, Alex Sickler, Aylar Babaei, Jo Lynne Rokita, Dalia Haydar
openRxiv  ·  23 Oct 2026  ·  doi:10.64898/2026.10.21.760687
Human leucocyte antigen class I and II alleles are associated with tumor susceptibility in neurofibromatosis type 1
Jonathan H. Sussman, Stephanie N. Brosius, Bernat Gel, Peiyao Li, Alvin Farrel, …, Eduard Serra, Kai Tan, Michael J. Fisher, John M. Maris, Thomas De Raedt
Frontiers in Immunology  ·  19 Oct 2026  ·  doi:10.3389/fimmu.2026.1966259
MOSAIC: Learning Graph Node Embeddings from Spectrally Isolated Dominant Subspaces of Accumulated Diffusion Operators.
Taha Mohseni Ahooyi, Benjamin J Stear, Yuanchao Zhang, Aditya Lahiri, James Terry, …, Christopher Nemarich, Jo Lynne Rokita, Sharon Diskin, Jonathan C Silverstein, Deanne M Taylor
bioRxiv : the preprint server for biology  ·  06 Oct 2026  ·  pubmed:42926505
Proteogenomic analysis of pediatric and AYA high-grade glioma reveals age-dependent biology, female-male differences, and kinase targets.
Nicole L Tignor, Mateusz Koptyra, Shrabanti Chowdhury, Francesca Petralia, Marina A Gritsenko, …, Amanda G Paulovich, Tao Liu, Adam Resnick, Brian R Rood, Pei Wang
Cell reports. Medicine  ·  17 Sep 2026  ·  pubmed:42753723
Tumor Microenvironmental Regulation of CAR T-Cell Therapy in High Risk Medulloblastoma.
Serge Yaacoub, Mostafa Seblani, Kaleem Coleman, Zhongzhen Yi, Kyoungtea Kim, …, Timothy Gershon, Jo Lynne Rokita, Martine F Roussel, Marina Sokolsky-Papkov, Dalia Haydar
Research square  ·  21 May 2026  ·  pubmed:42239754
Alternative splicing in pediatric central nervous system tumors highlights oncofetal candidate
Ammar S Naqvi, Patricia J Sullivan, Ryan J Corbett, Priyanka Sehgal, Karina L Conkrite, …, Peter J Madsen, Sharon J Diskin, Andrei Thomas-Tikhonenko, Adam C Resnick, Jo Lynne Rokita
Neuro-oncology pediatrics  ·  16 Feb 2026  ·  pubmed:41908886

2025

Germline pathogenic variation impacts somatic alterations and patient outcomes in pediatric central nervous system tumors.
Ryan J Corbett, Rebecca S Kaufman, Shelly W McQuaid, Zalman Vaksman, Saksham Phul, …, Angela J Waanders, Miriam Bornhorst, Suzanne P MacFarland, Jo Lynne Rokita, Sharon J Diskin
Nature communications  ·  21 Nov 2025  ·  pubmed:41271695
Germline analysis of an international cohort of pediatric diffuse midline glioma patients.
Marion K Mateos, Pamela Ajuyah, Noemi Fuentes-Bolanos, Sam El-Kamand, Paulette Barahona, …, Sebastien Perreault, Chris Jones, Marie Wong-Erasmus, Mark J Cowley, David S Ziegler
Neuro-oncology  ·  08 Sep 2025  ·  pubmed:40072012
Kinome Reprogramming of G2/M Kinases and Repression of MYCN Contribute to Superior Efficacy of Lorlatinib in ALK-Driven Neuroblastoma.
Smita Matkar, Michael P East, Timothy J Stuhlmiller, Gabriela M Witek, Alvin Farrel, …, Jo Lynne Rokita, Mark Gerelus, John M Maris, Gary L Johnson, Yael P Mossé
Molecular cancer therapeutics  ·  02 Sep 2025  ·  pubmed:39907037
NRCAM variant defined by microexon skipping is a targetable cell surface proteoform in high-grade gliomas.
Priyanka Sehgal, Ammar S Naqvi, Makenna Higgins, Jiageng Liu, Kyra Harvey, …, Adam C Resnick, Hagen U Tilgner, Thomas De Raedt, Daniel J Powell, Andrei Thomas-Tikhonenko
Cell reports  ·  07 Aug 2025  ·  pubmed:40782352
Imaging Clusters of Pediatric Low-Grade Glioma Are Associated with Distinct Molecular Characteristics.
Anahita Fathi Kazerooni, Adam Kraya, Komal S Rathi, Meen Chul Kim, Varun Kesherwani, …, Sabine Mueller, Jo Lynne Rokita, Michael J Fisher, Adam C Resnick, Ali Nabavizadeh
AJNR. American journal of neuroradiology  ·  01 Aug 2025  ·  pubmed:39952665
Genetic ancestry superpopulations show distinct prevalence and outcomes across pediatric central nervous system tumors from the Pediatric Brain Tumor Atlas and Pediatric Neuro-Oncology Consortium.
Ryan J Corbett, Cricket C Gullickson, Zhuangzhuang Geng, Miguel A Brown, Bo Zhang, …, Angela J Waanders, Sebastian M Waszak, Sabine Mueller, Jo Lynne Rokita, Cassie Kline
Neuro-oncology  ·  21 Jun 2025  ·  pubmed:39847453
Germline Pathogenic DROSHA Variants Are Linked to Pineoblastoma and Wilms Tumor Predisposition.
Peter N Fiorica, Lisa Golmard, Jung Kim, Riyue Bao, Frank Y Lin, …, Douglas R Stewart, D Williams Parsons, Sharon E Plon, Kris Ann P Schultz, Kenan Onel
Clinical cancer research : an official journal of the American Association for Cancer Research  ·  14 Apr 2025  ·  pubmed:39992227
The Open Pediatric Cancer Project
Zhuangzhuang Geng, Eric Wafula, Ryan J Corbett, Yuanchao Zhang, Run Jin, …, Chuwei Zhong, Joseph M Dybas, Pei Wang, Deanne Taylor, Jo Lynne Rokita
GigaScience  ·  01 Jan 2025  ·  doi:10.1093/gigascience/giaf093

2024

A proteogenomic surfaceome study identifies DLK1 as an immunotherapeutic target in neuroblastoma.
Amber K Hamilton, Alexander B Radaoui, Matthew Tsang, Daniel Martinez, Karina L Conkrite, …, Patrick H van Berkel, Malcolm A Smith, Benjamin A Garcia, John M Maris, Sharon J Diskin
Cancer cell  ·  24 Oct 2024  ·  pubmed:39454577
AutoGVP: a dockerized workflow integrating ClinVar and InterVar germline sequence variant classification.
Jung Kim, Ammar S Naqvi, Ryan J Corbett, Rebecca S Kaufman, Zalman Vaksman, …, Phillip B Storm, Adam C Resnick, Douglas R Stewart, Jo Lynne Rokita, Sharon J Diskin
Bioinformatics (Oxford, England)  ·  29 Feb 2024  ·  pubmed:38426335
BARD1 germline variants induce haploinsufficiency and DNA repair defects in neuroblastoma.
Michael P Randall, Laura E Egolf, Zalman Vaksman, Minu Samanta, Matthew Tsang, …, Mehdi Layeghifard, Adam Shlien, John M Maris, Sharon J Diskin, Kristopher R Bosse
Journal of the National Cancer Institute  ·  10 Jan 2024  ·  pubmed:37688570

2023

Everolimus for Children With Recurrent or Progressive Low-Grade Glioma: Results From the Phase II PNOC001 Trial.
Daphne A Haas-Kogan, Mariam S Aboian, Jane E Minturn, Sarah E S Leary, Mohamed S Abdelbaki, …, Joanna J Phillips, Michael Prados, Annette M Molinaro, Sebastian M Waszak, Sabine Mueller
Journal of clinical oncology : official journal of the American Society of Clinical Oncology  ·  17 Nov 2023  ·  pubmed:37978951
Alternative lengthening of telomeres (ALT) in pediatric high-grade gliomas can occur without ATRX mutation and is enriched in patients with pathogenic germline mismatch repair (MMR) variants.
Jennifer L Stundon, Heba Ijaz, Krutika S Gaonkar, Rebecca S Kaufman, Run Jin, …, Suzanne P MacFarland, Douglas R Stewart, Sharon J Diskin, Jo Lynne Rokita, Kristina A Cole
Neuro-oncology  ·  06 Jul 2023  ·  pubmed:36541551
OpenPBTA: The Open Pediatric Brain Tumor Atlas.
Joshua A Shapiro, Krutika S Gaonkar, Stephanie J Spielman, Candace L Savonen, Chante J Bethell, …, Miguel A Brown, Adam C Resnick, Casey S Greene, Jo Lynne Rokita, Jaclyn N Taroni
Cell genomics  ·  31 May 2023  ·  pubmed:37492101
Identification of candidate genes for nicotine withdrawal in C57BL/6J × DBA/2J recombinant inbred mice
Maren L. Smith, Kristin M. Mignogna, Jo L. Rokita, Lorna MacLeod, M. Imad Damaj, Michael F. Miles
Genes, Brain and Behavior  ·  13 Feb 2023  ·  doi:10.1111/gbb.12844
Identification of candidate genes for nicotine withdrawal in C57BL/6J × DBA/2J recombinant inbred mice.
Maren L Smith, Kristin M Mignogna, Jo L Rokita, Lorna MacLeod, M Imad Damaj, Michael F Miles
Genes, brain, and behavior  ·  13 Feb 2023  ·  pubmed:36781202
Enhancing childhood cancer targetability.
Ammar S Naqvi, Jo Lynne Rokita
Nature cancer  ·  01 Feb 2023  ·  pubmed:36585448

2022

The children's brain tumor network (CBTN) - Accelerating research in pediatric central nervous system tumors through collaboration and open science.
Jena V Lilly, Jo Lynne Rokita, Jennifer L Mason, Tatiana Patton, Stephanie Stefankiewiz, …, Phillip B Storm, Rishi R Lulla, Michael Prados, Adam C Resnick, Angela J Waanders
Neoplasia (New York, N.Y.)  ·  03 Nov 2022  ·  pubmed:36335802
Upfront Biology-Guided Therapy in Diffuse Intrinsic Pontine Glioma: Therapeutic, Molecular, and Biomarker Outcomes from PNOC003.
Cassie Kline, Payal Jain, Lindsay Kilburn, Erin R Bonner, Nalin Gupta, …, Michael Prados, Adam Resnick, Sebastian M Waszak, Javad Nazarian, Sabine Mueller
Clinical cancer research : an official journal of the American Association for Cancer Research  ·  15 Sep 2022  ·  pubmed:35852795
Development of GPC2-directed chimeric antigen receptors using mRNA for pediatric brain tumors.
Jessica B Foster, Crystal Griffin, Jo Lynne Rokita, Allison Stern, Cameron Brimley, …, Phillip B Storm, David M Barrett, Adam C Resnick, John M Maris, Kristopher R Bosse
Journal for immunotherapy of cancer  ·  01 Sep 2022  ·  pubmed:36167467

2021

Macrophages in SHH subgroup medulloblastoma display dynamic heterogeneity that varies with treatment modality.
Mai T Dang, Michael V Gonzalez, Krutika S Gaonkar, Komal S Rathi, Patricia Young, …, Candace Savonen, Fernanda Mafra, Hakon Hakonarson, Tom Curran, Malay Haldar
Cell reports  ·  30 Mar 2021  ·  pubmed:33789113
GAS7 Deficiency Promotes Metastasis in MYCN-Driven Neuroblastoma.
Zhiwei Dong, Kok Siong Yeo, Gonzalo Lopez, Cheng Zhang, Erin N Dankert Eggum, …, Jan M van Deursen, Hu Li, Jennifer J Westendorf, John M Maris, Shizhen Zhu
Cancer research  ·  18 Feb 2021  ·  pubmed:33602789

2020

annoFuse: an R Package to annotate, prioritize, and interactively explore putative oncogenic RNA fusions.
Krutika S Gaonkar, Federico Marini, Komal S Rathi, Payal Jain, Yuankun Zhu, …, Pichai Raman, Adam C Resnick, Konstantin Strauch, Jaclyn N Taroni, Jo Lynne Rokita
BMC bioinformatics  ·  14 Dec 2020  ·  pubmed:33317447
Integrated Proteogenomic Characterization across Major Histological Types of Pediatric Brain Cancer.
Francesca Petralia, Nicole Tignor, Boris Reva, Mateusz Koptyra, Shrabanti Chowdhury, …, Amanda G Paulovich, Adam C Resnick, Phillip B Storm, Brian R Rood, Pei Wang
Cell  ·  25 Nov 2020  ·  pubmed:33242424
A transcriptome-based classifier to determine molecular subtypes in medulloblastoma.
Komal S Rathi, Sherjeel Arif, Mateusz Koptyra, Ammar S Naqvi, Deanne M Taylor, Phillip B Storm, Adam C Resnick, Jo Lynne Rokita, Pichai Raman
PLoS computational biology  ·  29 Oct 2020  ·  pubmed:33119584
LIN28B promotes neuroblastoma metastasis and regulates PDZ binding kinase.
Dongdong Chen, Julie Cox, Jayabhargav Annam, Melanie Weingart, Grace Essien, …, Daisy Li, Cara Shields, Oskar Laur, John M Maris, Robert W Schnepp
Neoplasia (New York, N.Y.)  ·  24 Apr 2020  ·  pubmed:32339949
Limited antitumor activity of combined BET and MEK inhibition in neuroblastoma.
Jason R Healy, Lori S Hart, Alexander L Shazad, Maria E Gagliardi, Matthew Tsang, …, Olena Barbash, Vandana Batra, Minu Samanta, John M Maris, Robert W Schnepp
Pediatric blood & cancer  ·  19 Apr 2020  ·  pubmed:32307821
Epigenomic profiling of neuroblastoma cell lines.
Kristen Upton, Apexa Modi, Khushbu Patel, Nathan M Kendsersky, Karina L Conkrite, …, Gregory I Sacks, Paolo Fortina, Sharon J Diskin, John M Maris, Jo Lynne Rokita
Scientific data  ·  14 Apr 2020  ·  pubmed:32286315
Telomere Maintenance Mechanisms Define Clinical Outcome in High-Risk Neuroblastoma.
Balakrishna Koneru, Gonzalo Lopez, Ahsan Farooqi, Karina L Conkrite, Thinh H Nguyen, …, Shengping Yang, David A Wheeler, John M Maris, Sharon J Diskin, C Patrick Reynolds
Cancer research  ·  14 Apr 2020  ·  pubmed:32291317
CAMKV Is a Candidate Immunotherapeutic Target in
Robyn T Sussman, Jo Lynne Rokita, Kevin Huang, Pichai Raman, Komal S Rathi, …, Maria Lane, Lori S Hart, Tricia Bhatti, Bruce Pawel, John M Maris
Frontiers in oncology  ·  06 Mar 2020  ·  pubmed:32211329
Pediatric high-grade glioma resources from the Children's Brain Tumor Tissue Consortium.
Heba Ijaz, Mateusz Koptyra, Krutika S Gaonkar, Jo Lynne Rokita, Valerie P Baubet, …, Maria Rita Santi, Phillip B Storm, Adam Resnick, Angela J Waanders, Kristina A Cole
Neuro-oncology  ·  11 Jan 2020  ·  pubmed:31613963

2019

ASCL1 is a MYCN- and LMO1-dependent member of the adrenergic neuroblastoma core regulatory circuitry.
Lu Wang, Tze King Tan, Adam D Durbin, Mark W Zimmerman, Brian J Abraham, …, Jo Lynne Rokita, John M Maris, Richard A Young, A Thomas Look, Takaomi Sanda
Nature communications  ·  09 Dec 2019  ·  pubmed:31819055
Combined innate and adaptive immunotherapy overcomes resistance of immunologically cold syngeneic murine neuroblastoma to checkpoint inhibition.
Julie Voeller, Amy K Erbe, Jacob Slowinski, Kayla Rasmussen, Peter M Carlson, …, John Maris, Jacquelyn A Hank, Zachary S Morris, Alexander L Rakhmilevich, Paul M Sondel
Journal for immunotherapy of cancer  ·  06 Dec 2019  ·  pubmed:31810498
Genomic Profiling of Childhood Tumor Patient-Derived Xenograft Models to Enable Rational Clinical Trial Design.
Jo Lynne Rokita, Komal S Rathi, Maria F Cardenas, Kristen A Upton, Joy Jayaseelan, …, Malcolm A Smith, Richard B Lock, Pichai Raman, David A Wheeler, John M Maris
Cell reports  ·  05 Nov 2019  ·  pubmed:31693904
YAP1 Mediates Resistance to MEK1/2 Inhibition in Neuroblastomas with Hyperactivated RAS Signaling.
Grace E Coggins, Alvin Farrel, Komal S Rathi, Colin M Hayes, Laura Scolaro, Jo Lynne Rokita, John M Maris
Cancer research  ·  31 Oct 2019  ·  pubmed:31672841
Germline 16p11.2 Microdeletion Predisposes to Neuroblastoma.
Laura E Egolf, Zalman Vaksman, Gonzalo Lopez, Jo Lynne Rokita, Apexa Modi, Patricia V Basta, Hakon Hakonarson, Andrew F Olshan, Sharon J Diskin
American journal of human genetics  ·  29 Aug 2019  ·  pubmed:31474320
The Pediatric Cell Atlas: Defining the Growth Phase of Human Development at Single-Cell Resolution.
Deanne M Taylor, Bruce J Aronow, Kai Tan, Kathrin Bernt, Nathan Salomonis, …, Yi Xing, Sek Won Kong, Carsten G Bönnemann, Kenneth D Mandl, Peter S White
Developmental cell  ·  28 Mar 2019  ·  pubmed:30930166

2018

Cross-Cohort Analysis Identifies a TEAD4-MYCN Positive Feedback Loop as the Core Regulatory Element of High-Risk Neuroblastoma.
Presha Rajbhandari, Gonzalo Lopez, Claudia Capdevila, Beatrice Salvatori, Jiyang Yu, …, Antonio Iavarone, Anna Lasorella, Jose M Silva, John M Maris, Andrea Califano
Cancer discovery  ·  06 Mar 2018  ·  pubmed:29510988

2017

Identification of GPC2 as an Oncoprotein and Candidate Immunotherapeutic Target in High-Risk Neuroblastoma.
Kristopher R Bosse, Pichai Raman, Zhongyu Zhu, Maria Lane, Daniel Martinez, …, Marco A Marra, Michael D Taylor, Dimiter S Dimitrov, Crystal L Mackall, John M Maris
Cancer cell  ·  11 Sep 2017  ·  pubmed:28898695
Transcriptomic profiling of 39 commonly-used neuroblastoma cell lines.
Jo Lynne Harenza, Maura A Diamond, Rebecca N Adams, Michael M Song, Heather L Davidson, Lori S Hart, Maiah H Dent, Paolo Fortina, C Patrick Reynolds, John M Maris
Scientific data  ·  28 Mar 2017  ·  pubmed:28350380

2016

International Comparison of Enumeration-Based Quantification of DNA Copy-Concentration Using Flow Cytometric Counting and Digital Polymerase Chain Reaction.
Hee-Bong Yoo, Sang-Ryoul Park, Lianhua Dong, Jing Wang, Zhiwei Sui, …, Jim F Huggett, Helen Parkes, Margaret C Kline, Jo Lynne Harenza, Peter M Vallone
Analytical chemistry  ·  30 Nov 2016  ·  pubmed:28193036
Identification of quantitative trait loci and candidate genes for an anxiolytic‐like response to ethanol inBXDrecombinant inbred strains
A. H. Putman, A. R. Wolen, J. L. Harenza, R. K. Yordanova, B. T. Webb, E. J. Chesler, M. F. Miles
Genes, Brain and Behavior  ·  01 Apr 2016  ·  doi:10.1111/gbb.12289

2015

Inhibition of monoacylglycerol lipase reduces nicotine withdrawal
P P Muldoon, J Chen, J L Harenza, R A Abdullah, L J Sim‐Selley, B F Cravatt, M F Miles, X Chen, A H Lichtman, M I Damaj
British Journal of Pharmacology  ·  08 Jan 2015  ·  doi:10.1111/bph.12948

2014

The α3β4* nicotinicAChreceptor subtype mediates physical dependence to morphine: mouse and human studies
P P Muldoon, K J Jackson, E Perez, J L Harenza, S Molas, …, M Dierssen, M F Miles, X Chen, M De Biasi, M I Damaj
British Journal of Pharmacology  ·  25 Jul 2014  ·  doi:10.1111/bph.12741

2013

Genetic variation within theChrna7gene modulates nicotine reward‐like phenotypes in mice
J. L. Harenza, P. P. Muldoon, M. De Biasi, M. I. Damaj, M. F. Miles
Genes, Brain and Behavior  ·  26 Dec 2013  ·  doi:10.1111/gbb.12113

2011

The Neuropeptide Galanin and Variants in the GalR1 Gene are Associated with Nicotine Dependence
Kia J Jackson, Xiangning Chen, Michael F Miles, JoLynne Harenza, M Imad Damaj
Neuropsychopharmacology  ·  27 Jul 2011  ·  doi:10.1038/npp.2011.123
Genetic analysis of the neurosteroid deoxycorticosterone and its relation to alcohol phenotypes: identification of QTLs and downstream gene regulation.
Patrizia Porcu, Todd K O’Buckley, Soomin C Song, Jo Lynne Harenza, Lu Lu, Xusheng Wang, Robert W Williams, Michael F Miles, A Leslie Morrow
PloS one  ·  08 Apr 2011  ·  pubmed:21494628

List projects

TAPESTRY
TAPESTRY Tumor Alternative PEdiatric Splicing visualizaTion and queRYing

An interactive web application and API for exploring tumor-enriched splice junctions across pediatric brain tumors. Explore it at tapestry.rokitalab.com.

OpenPedCanExpress
OpenPedCanExpress Pediatric tumor vs. normal expression explorer

A lightweight web application for comparing gene expression in pediatric tumors against normal tissue controls, with publication-ready plot export.

OpenPedCan
OpenPedCan The Open Pediatric Cancer Project

A harmonized open-source multi-omic dataset from > 6,000 pediatric cancer patients with > 7,000 tumor events across more than 100 histologies.

OpenPBTA
OpenPBTA The Open Pediatric Brain Tumor Atlas

A global open science initiative, co-led with the Childhood Cancer Data Lab, characterizing over 1,000 pediatric brain tumors.

AutoGVP
AutoGVP Automated Germline Variant Pathogenicity

A dockerized workflow integrating ClinVar and InterVar germline sequence variant classification, with a companion CAVATICA preprocessing app.

annoFuse
annoFuse BMC Bioinformatics, 2020

An R package and companion RShiny application to annotate, prioritize, and interactively explore putative oncogenic RNA fusions.

Medulloblastoma subtype classifier
Medulloblastoma subtype classifier PLOS Computational Biology, 2020

A transcriptome-based classifier that assigns medulloblastoma samples to WNT, SHH, Group 3, and Group 4 subtypes using gene expression ratios.

CLK1 splicing as a target in pediatric CNS tumors
CLK1 splicing as a target in pediatric CNS tumors Neuro-Oncology Pediatrics, 2026

Alternative splicing in pediatric central nervous system tumors highlights oncofetal candidate CLK1 exon 4.

Germline variation in pediatric CNS tumors
Germline variation in pediatric CNS tumors Nature Communications, 2025

Germline pathogenic variation impacts somatic alterations and patient outcomes in pediatric central nervous system tumors.

NRCAM microexon skipping in high-grade gliomas
NRCAM microexon skipping in high-grade gliomas Cell Reports, 2025

An NRCAM variant defined by microexon skipping is a targetable cell surface proteoform in high-grade gliomas.

Genetic ancestry associated disparities
Genetic ancestry associated disparities Neuro-Oncology, 2025

Distinct associations of genetic ancestry-based superpopulations exist within pediatric CNS tumor histologic and molecular subtypes and correlate with survival outcomes and treatment.


List team members


List blog posts

2026

Dr. Goswami wins first place abstract at the CHARM symposium
Dr. Goswami wins first place abstract at the CHARM symposium

CONGRATULATIONS to our Staff Scientist, Dr. Meghali Goswami, for winning first place abstract and giving a lightning talk at the CHARM symposium, the 4th Annual Cell and Gene Therapy Symposium in the Mid-Atlantic Region! 🏆

TAPESTRY preprint is online
TAPESTRY preprint is online!

We are excited to share our preprint, “TAPESTRY: an interactive resource for exploring tumor-enriched splice junctions in pediatric brain tumors,” now on arXiv! This work was spearheaded by Dr. Patricia Sullivan, with underlying data generated by Dr. Ryan Corbett and infrastructure support by Dr. Chao Di.

Rokita Lab shines at the GW Bioinformatics Symposium
Rokita Lab shines at the GW Bioinformatics Symposium

What a day at the GW Bioinformatics Symposium! 🎉

Dr. Rokita begins mentoring postdocs at CHOP
Dr. Rokita begins mentoring postdocs at CHOP

Dr. Rokita has started volunteering as a postdoctoral mentor through the Children’s Hospital of Philadelphia (CHOP) mentoring program! As a former CHOP postdoc herself, she is excited to give back by supporting the next generation of researchers at the institution where she spent nearly a decade of her career.

Introducing OpenPedCanExpress
Introducing OpenPedCanExpress

We are excited to share OpenPedCanExpress, a new web tool for exploring gene expression across pediatric tumors and normal tissue controls! Search any gene and instantly compare its expression in pediatric brain tumors against normal brain tissue, all in your browser with no code required.

Dr. Rokita joins the PBTF Technology Advisory Network
Dr. Rokita joins the PBTF Technology Advisory Network

Dr. Rokita has joined the Pediatric Brain Tumor Foundation (PBTF) Technology Advisory Network (TAN)!

Remembering John Matthew for Childhood Cancer Awareness Month
Remembering John Matthew for Childhood Cancer Awareness Month

On this last day of Childhood Cancer Awareness Month, I’m remembering my little cousin, John Matthew Dean. John Matthew was born on November 21, 1993, and passed away in August of 1998 after a battle with a malignant brain tumor. He was four years old.

Rokita Lab returns to AACR Pediatrics
Rokita Lab returns to AACR Pediatrics

So proud of Dr. Ryan Corbett and Dr. Meg Goswami, who represented the Rokita Lab at the 2026 American Association for Cancer Research (AACR) Pediatric Cancer Conference! 🎉

Dylan Mach joins the Rokita Lab
Dylan Mach joins the Rokita Lab!

We are excited to welcome Dylan Mach, a second-year undergraduate student at The George Washington University, to the Rokita Lab 🎉. Dylan is majoring in Biology and minoring in Statistics, and is part of GWU’s Seven-Year BA/MD program.

Our very first Rokita Lab retreat
Our very first Rokita Lab retreat!

So grateful for 1.5 days of dedicated Rokita Lab time this week with our amazing scientist team — Dr. Ryan Corbett, Dr. Patricia Sullivan, Dr. Meg Goswami, and Dr. Chao Di.

Congratulations to Deborah on a successful METEOR summer internship
Congratulations to Deborah on a successful METEOR summer internship!

Congratulations to Deborah Torrico-Pardo on wrapping up a successful summer internship in the Rokita Lab, mentored by Dr. Meg Goswami!

A great day at the CCIR Retreat
A great day at the CCIR Retreat

It was great to be back at Children’s National Hospital for the annual Center for Cancer and Immunology Research (CCIR) Retreat!

BTI Bioinformatics Core dedicates a retreat to engineering and automation
BTI Bioinformatics Core dedicates a retreat to engineering and automation

While part of the team was on the other side of the world at ISPNO, Bailey, Rehman, Alex, and Aylar spent a day and a half at a focused Bioinformatics Operations retreat, dedicated entirely to engineering and automation.

Rokita Lab science on display at ISPNO in Sydney
Rokita Lab science on display at ISPNO in Sydney

The Rokita Lab traveled to Sydney this week for the International Symposium on Pediatric Neuro-Oncology (ISPNO), where we shared our latest work with the global pediatric neuro-oncology community.

Deborah Torrico-Pardo joins the Rokita Lab
Deborah Torrico-Pardo joins the Rokita Lab!

We are excited to welcome high school summer student, Deborah Torrico-Pardo, to the Rokita Lab at Children’s National Hospital (CNH) 🎉. Deborah was selected through the prestigious METEOR Summer Program at Children’s National Hospital and will work on preclinical validation of a tumor-enriched splice event in pediatric brain tumors.

Dr. Kaylyn Clark selected to participate in TEAMS program
Dr. Kaylyn Clark selected to participate in TEAMS program!

Congratulations to Dr. Kaylyn Clark on being selected for the TEAMS training program.

Representing the Rokita and Gilbert Labs at the GWU Cancer Center retreat
Representing the Rokita and Gilbert Labs at the GWU Cancer Center retreat

Proud to see Jacob White, Dr. Kaylyn Clark, and Dr. Meg Goswami represent the Rokita and Gilbert Labs at this year’s George Washington University Cancer Center retreat!

Dr. Patricia Sullivan awarded an ALSF Young Investigator Award
Dr. Patricia Sullivan awarded an ALSF Young Investigator Award!

Congratulations to Dr. Patricia Sullivan on being awarded a prestigious Young Investigator Grant from Alex’s Lemonade Stand Foundation (ALSF)!

Jacob White awarded a St. Baldrick s Summer Fellowship
Jacob White awarded a St. Baldrick's Summer Fellowship!

Congratulations to Jacob White for being awarded a summer fellowship from St. Baldrick’s Foundation! Jacob’s project “Association of genetic ancestry with pediatric CNS tumor splicing” will support the lab’s pediatric brain tumor research by identifying genetic determinants of alternative splicing and their contributions to disease.

Dr. Rehman Qureshi joins the Brain Tumor Institute Bioinformatics Core as Assistant Director
Dr. Rehman Qureshi joins the Brain Tumor Institute Bioinformatics Core as Assistant Director!

We are thrilled to welcome Dr. Rehman Qureshi as Assistant Director of the Brain Tumor Institute Bioinformatics Core at Children’s National Hospital (CNH) 🎉.

A strong showing at Children s National Research, Education, and Innovation week
A strong showing at Children's National Research, Education, and Innovation week!

Congratulations to Children’s National Hospital on another outstanding Research, Education, and Innovation (REI) week!

Vinay Gujjula awarded an ALSF POST Award
Vinay Gujjula awarded an ALSF POST Award!

Congratulations to Vinay Gujjula for being awarded a Pediatric Oncology Student Training (POST) Award from Alex’s Lemonade Stand Foundation (ALSF). Vinay’s project “Investigating the association of genetic ancestry with pathogenic variation in pediatric patients with brain tumors” will support the lab’s germline variant analysis and broader pediatric brain tumor research through ancestry-informed computational analyses of large pediatric cancer datasets.

Our study of RNA splicing across pediatric brain tumors is now published in Neuro-Oncology Pediatrics!

We are excited to share the publication of our latest study, “Alternative splicing in pediatric central nervous system tumors highlights oncofetal candidate CLK1 exon 4,” now published in Neuro-Oncology Pediatrics. Led by co-first authors Dr. Ammar Naqvi and Dr. Patricia Sullivan, this work represents years of collaborative effort across institutions and builds on our ongoing mission to understand the molecular programs that shape pediatric brain tumors.

Bailey Farrow joins the BTI Bioinformatics Core Leadership
Bailey Farrow joins the BTI Bioinformatics Core Leadership!

We are thrilled to welcome Bailey Farrow to Children’s National Hospital (CNH) as our new Senior Bioinformatics Program and Operations Manager for the Brain Tumor Institute (BTI) Bioinformatics Core! 🎉

Jacob White joins the Rokita Lab
Jacob White joins the Rokita Lab!

We are excited to welcome masters student, Jacob White, to the Rokita Lab at Children’s National Hospital (CNH) 🎉. Jacob will begin his research by studying both mechanisms of RNA splicing in pediatric brain tumors and identifying tractable splice-derived therapeutic targets.

Vinay Gujjula joins the Rokita Lab
Vinay Gujjula joins the Rokita Lab!

We are excited to welcome masters student, Vinay Gujjula, to the Rokita Lab at Children’s National Hospital (CNH) 🎉. Vinay will begin his research by investigating the inheritance of pathogenic or likely pathogenic germline variants in pediatric brain tumors.

2025

Our integrative analysis of PBTA host-tumor genomes has been published in Nature Communications!

We’re thrilled to share the publication of our latest study, “Germline pathogenic variation impacts somatic alterations and patient outcomes in pediatric central nervous system tumors,” now out in Nature Communications. Led by Dr. Ryan Corbett in the Rokita Lab, this work represents a comprehensive multi-omic analysis of germline and somatic data from 830 pediatric brain tumor patients in the #PBTA — truly a tour de force by the team.

Dr. Meghali Goswami joins the Rokita Lab
Dr. Meghali Goswami joins the Rokita Lab!

We are excited to welcome Dr. Meghali (Meg) Goswami as a Staff Scientist in the Rokita Lab at Children’s National Hospital (CNH) 🎉. Meg joins us from the National Cancer Institute, where she became a leading expert in tumor immunology, translational research, and biomarker discovery for immuno-oncology therapies.

Dr. Shang-Yang Sam Chen joins the Brain Tumor Institute Bioinformatics Core
Dr. Shang-Yang (Sam) Chen joins the Brain Tumor Institute Bioinformatics Core!

We are excited to welcome Dr. Shang-Yang (Sam) Chen as a Bioinformatics Scientist in the Brain Tumor Institute Bioinformatics Core at Children’s National Hospital (CNH) 🎉.

Representing the Rokita Lab at AACR Pediatrics
Representing the Rokita Lab at AACR Pediatrics

Grateful and proud of Ryan Corbett and Dr. Patricia Sullivan for attending the American Association for Cancer Research (AACR) Pediatric Cancer Conference on behalf of the Rokita Lab, in our very first year as a lab!

From Foundation to Future: Dr. Rokita presents the first year of the BTI Bioinformatics Core
From Foundation to Future: Dr. Rokita presents the first year of the BTI Bioinformatics Core

At this year’s Center for Cancer and Immunology Research (CCIR) Retreat, Dr. Rokita gave a talk, entitled, “From Foundation to Future: The First Year of the BTI Bioinformatics Core.”

Dr. Corbett named as 2025 CCF NextGen Awardee
Dr. Corbett named as 2025 CCF NextGen Awardee!

We are thrilled to announce that Dr. Ryan Corbett has been selected as the 2025 NextGen Awardee by the Children’s Cancer Foundation for his grant entitled, “Identification and functional targeting of alternative splice site usage in pediatric high-grade gliomas”.

Akhil Chada joins the Rokita Lab
Akhil Chada joins the Rokita Lab!

We are excited to welcome Akhil Chada to the Rokita Lab at Children’s National Hospital (CNH) 🎉. Akhil joins us as a summer student and rising high school senior at James Madison High School in Fairfax County, Virginia. He brings expertise in several coding languages (Python, C++, R, and Java) and advanced mathematics.

The Open Pediatric Cancer manuscript has been accepted for publication!

We are excited to announce that our large, collaborative work on the Open Pediatric Cancer (OpenPedCan) Project has been accepted in GigaScience! We are very grateful for the many researchers, clinicians, engineers, bioinformaticians, and investigators who have contributed to this work – a true team effort! Read the preprint here.

New collaborative manuscript identifying and testing a splice event in the NRCAM gene has been accepted in Cell Reports!

We were thrilled to contribute to the recently accepted manuscript, “NRCAM variant defined by microexon skipping is an essential, antigenically distinct, and targetable surface proteoform in high-grade gliomas”, led by the lab of collaborator Dr. Andrei Thomas-Tikhonenko. In this project, we identified a tumor-specific exon inclusion event in the NRCAM gene as a new therapeutic target. Read the preprint here.

Aylar Babaei joins the BTI Bioinformatics Core
Aylar Babaei joins the BTI Bioinformatics Core!

We are thrilled to announce Aylar Babaei as a Bioinformatics Scientist in the BTI Bioinformatics Core at Children’s National Hospital (CNH) 🎉. Aylar joins the Core after a productive year right here at CNH, where she contributed to multiple computational workflows, including Ribo-seq analysis, HLA typing, and MHC class I epitope prediction. She brings hands-on experience running large-scale pipelines on the high-performance computing (HPC) environment.

Dr. Chao Di joins the Rokita Lab and Brain Tumor Institute Bioinformatics Core
Dr. Chao Di joins the Rokita Lab and Brain Tumor Institute Bioinformatics Core!

We are excited to welcome Dr. Chao Di as a Senior Bioinformatics Engineer and Scientist in the Rokita Lab and the Brain Tumor Institute Bioinformatics Core at Children’s National Hospital (CNH) 🎉.

Dr. Patricia Sullivan joins the Rokita Lab
Dr. Patricia Sullivan joins the Rokita Lab!

We are excited to announce the arrival of Dr. Patricia Sullivan as a Bioinformatics Scientist in the Rokita Lab at Children’s National Hospital (CNH) 🎉. Patricia joins us from the Children’s Cancer Institute in Sydney, where she became a leading expert in splice-altering variation in pediatric cancer and rare disease genomics.

Dr. Jessica Daggett joins the Brain Tumor Institute Bioinformatics Core
Dr. Jessica Daggett joins the Brain Tumor Institute Bioinformatics Core!

We are happy to announce our recruitment of Dr. Jessica Daggett as a Bioinformatics Scientist in the Brain Tumor Institute (BTI) Bioinformatics Core at Children’s National Hospital (CNH) 🎉.

Dr. Kaylyn Clark joins the Rokita Lab and Brain Tumor Institute
Dr. Kaylyn Clark joins the Rokita Lab and Brain Tumor Institute!

We are happy to announce our recruitment of Dr. Kaylyn Clark as a Postdoctoral Fellow in the Rokita Lab and Brain Tumor Institute (BTI) at Children’s National Hospital (CNH) 🎉.

New collaborative manuscript exploring germline pathogenic variation in pediatric DMGs published!

We were thrilled to contribute to the recent publication, “Germline analysis of an international cohort of pediatric diffuse midline glioma patients”, led by collaborator Dr. Marion Mateos. In this project, we assessed pathogenicity of germline variants driving DIPG and DMG. Read more about it here.

Dr. Bicna Song joins the Brain Tumor Institute Bioinformatics Core
Dr. Bicna Song joins the Brain Tumor Institute Bioinformatics Core!

We are happy to announce our recruitment of Dr. Bicna Song as a Bioinformatics Scientist in the Brain Tumor Institute (BTI) Bioinformatics Core at Children’s National Hospital (CNH) 🎉.

New press release - Q A with Dr. Rokita: Building Bioinformatics Infrastructure at the Brain Tumor Institute
New press release - Q&A with Dr. Rokita: Building Bioinformatics Infrastructure at the Brain Tumor Institute

Dr. Rokita recently sat down with the press team at Children’s National to discuss her laboratory’s research, the development of the Brain Tumor Institute (BTI) Bioinformatics Core, and her collaborative and open science vision for the future. Read all about it here!

New tumor predisposition syndrome described!

We are happy to announce the publication of “Germline pathogenic DROSHA variants are linked to pineoblastoma and Wilms tumor predisposition”, an international collaboration in which we describe a new tumor syndrome characterized by pathogenic germline DROSHA variants. Read more about it here.

Alex Sickler joins the Rokita Lab
Alex Sickler joins the Rokita Lab!

We are thrilled to welcome Alex Sickler as a Bioinformatics Engineer in the Rokita Lab and Brain Tumor Institute (BTI) Bioinformatics Core at Children’s National Hospital (CNH) 🎉. Alex joins us after many productive years of bioinformatics engineering and infrastructure management work at GeneDx, the National Cancer Institute, and the Children’s Hospital of Philadelphia (CHOP).

Manuscript describing molecular features of low-grade glioma imaging clusters published!

We were thrilled to be a part of the recent publication, “Imaging Clusters of Pediatric Low-Grade Glioma are Associated with Distinct Molecular Characteristics”, led by our collaborator Dr. Anahita Fathi Kazerooni. Read more about it here.

Germline manuscript is online at medRxiv!

Our latest manuscript, “Germline pathogenic variation impacts somatic alterations and patient outcomes in pediatric CNS tumors”, work led by Dr. Ryan Corbett, is now preprinted on MedRxiv!

Kinome reprogramming in neuroblastoma manuscript published!

From Dr. Yael Mosse’s laboratory, we are happy to see the work of Dr. Smita Matkar, “Kinome reprogramming of G2/M kinases and repression of MYCN contribute to superior efficacy of lorlatinib in ALK-driven neuroblastoma”, published today. We were happy to have played a small role in this work! Read more about it here.

Preprint describing NRCAM, a new pediatric high-grade glioma neoepitope online!

As a part of our splice-derived neoepitope identification research, we partnered with Dr. Andrei Thomas-Tikhonenko’s laboratory at Children’s Hospital of Philadelphia in which they validated an NRCAM splice event as a targetable immunotherapeutic target for pediatric high-grade gliomas. Please read more in “Neuronal cell adhesion molecule (NRCAM) variant defined by microexon skipping is an essential, antigenically distinct, and targetable proteoform in high-grade glioma” here.

Dr. Ryan Corbett joins the Rokita Lab
Dr. Ryan Corbett joins the Rokita Lab!

We are thrilled to welcome Dr. Ryan Corbett as a Senior Bioinformatics Scientist in the Rokita Lab at Children’s National Hospital (CNH) 🎉. Ryan joins us after two years of outstanding work under the mentorship of Dr. Rokita at the Children’s Hospital of Philadelphia (CHOP).

2024

Genetic ancestry manuscript accepted at NeuroOncology!

Our newest manuscript, “Genetic ancestry superpopulations show distinct prevalence and outcomes across pediatric central nervous system tumors from the PBTA and PNOC”, work led by Dr. Ryan Corbett, has been accepted in NeuroOncology!

Rokita Lab opens at Children's National Hospital

We are thrilled to announce the opening of the Rokita Lab at Children’s National within the Brain Tumor Institute (BTI) and Center for Cancer and Immunology Research (CCIR)! Situated in a leading pediatric institution, our lab is equipped with cutting-edge technology and resources, fostering a collaborative environment for groundbreaking discoveries. We’re excited to accelerate our research and expand our efforts to improve outcomes for children with brain cancer.

Citation

[no title info]
[no publisher info]  ·  [no date info]  ·  [no id info]
[no title info]
[no publisher info]  ·  [no date info]  ·  [no id info]
Manual title
Manual authors
[no publisher info]  ·  [no date info]  ·  [no id info]

Card

A Large Card
A Large Card A cool card

A cool description

A Small Card
A Small Card A cool card

Lorem ipsum

Portrait

Post Excerpt

Manual title

Alert

Tip Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Help Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Info Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Success Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Warning Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Error Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Tags

Float

Figures

Caption
Caption

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

Code

const test = "Lorem ipsum dolor sit amet, consectetur adipiscing elit.";

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Nulla facilisi etiam dignissim diam quis. Id aliquet lectus proin nibh nisl condimentum id venenatis a. Tristique magna sit amet purus gravida quis blandit turpis cursus. Ultrices eros in cursus turpis massa tincidunt dui ut ornare. A cras semper auctor neque vitae tempus quam pellentesque nec. At tellus at urna condimentum mattis pellentesque. Ipsum consequat nisl vel pretium. Ultrices mi tempus imperdiet nulla malesuada pellentesque elit eget gravida. Integer vitae justo eget magna fermentum iaculis eu non diam. Mus mauris vitae ultricies leo integer malesuada nunc vel. Leo integer malesuada nunc vel risus. Ornare arcu odio ut sem nulla pharetra. Purus semper eget duis at tellus at urna condimentum. Enim neque volutpat ac tincidunt vitae semper quis lectus.

Grid

Regular

With Markdown images

image

image

image

image

image

image

Square

With figure components

Grid of citations

2026

The Common Fund Data Ecosystem
Julie A. Jurgens, Andreas Bueckle, Jeet Vora, Mano R. Maurya, Taha Mohseni Ahooyi, …, Kelli Bursey, Avi Ma’ayan, Raja Mazumder, Matthew E. Roth, Casey S. Greene
Patterns  ·  01 Nov 2026  ·  doi:10.1016/j.patter.2026.101714
Rokita Lab as CFDE consortium members
TAPESTRY: an interactive resource for exploring tumor-enriched splice junctions in pediatric brain tumors
Patricia J. Sullivan, Ryan J. Corbett, Chao Di, Alex Sickler, Aylar Babaei, Meghali Goswami, Jo Lynne Rokita
arXiv  ·  26 Oct 2026  ·  arxiv:2610.31816
Pan-pediatric brain tumor microRNA networks define immune microenvironment states and responses to CAR T-cell therapy
Kaleem Coleman, Ryan J Corbett, Zhongzhen Yi, Bicna Song, Alex Sickler, Aylar Babaei, Jo Lynne Rokita, Dalia Haydar
openRxiv  ·  23 Oct 2026  ·  doi:10.64898/2026.10.21.760687
Human leucocyte antigen class I and II alleles are associated with tumor susceptibility in neurofibromatosis type 1
Jonathan H. Sussman, Stephanie N. Brosius, Bernat Gel, Peiyao Li, Alvin Farrel, …, Eduard Serra, Kai Tan, Michael J. Fisher, John M. Maris, Thomas De Raedt
Frontiers in Immunology  ·  19 Oct 2026  ·  doi:10.3389/fimmu.2026.1966259
MOSAIC: Learning Graph Node Embeddings from Spectrally Isolated Dominant Subspaces of Accumulated Diffusion Operators.
Taha Mohseni Ahooyi, Benjamin J Stear, Yuanchao Zhang, Aditya Lahiri, James Terry, …, Christopher Nemarich, Jo Lynne Rokita, Sharon Diskin, Jonathan C Silverstein, Deanne M Taylor
bioRxiv : the preprint server for biology  ·  06 Oct 2026  ·  pubmed:42926505
Proteogenomic analysis of pediatric and AYA high-grade glioma reveals age-dependent biology, female-male differences, and kinase targets.
Nicole L Tignor, Mateusz Koptyra, Shrabanti Chowdhury, Francesca Petralia, Marina A Gritsenko, …, Amanda G Paulovich, Tao Liu, Adam Resnick, Brian R Rood, Pei Wang
Cell reports. Medicine  ·  17 Sep 2026  ·  pubmed:42753723
Tumor Microenvironmental Regulation of CAR T-Cell Therapy in High Risk Medulloblastoma.
Serge Yaacoub, Mostafa Seblani, Kaleem Coleman, Zhongzhen Yi, Kyoungtea Kim, …, Timothy Gershon, Jo Lynne Rokita, Martine F Roussel, Marina Sokolsky-Papkov, Dalia Haydar
Research square  ·  21 May 2026  ·  pubmed:42239754
Alternative splicing in pediatric central nervous system tumors highlights oncofetal candidate
Ammar S Naqvi, Patricia J Sullivan, Ryan J Corbett, Priyanka Sehgal, Karina L Conkrite, …, Peter J Madsen, Sharon J Diskin, Andrei Thomas-Tikhonenko, Adam C Resnick, Jo Lynne Rokita
Neuro-oncology pediatrics  ·  16 Feb 2026  ·  pubmed:41908886
Alternative splicing in pediatric central nervous system tumors highlights oncofetal candidate CLK1 exon 4

2025

Germline pathogenic variation impacts somatic alterations and patient outcomes in pediatric central nervous system tumors.
Ryan J Corbett, Rebecca S Kaufman, Shelly W McQuaid, Zalman Vaksman, Saksham Phul, …, Angela J Waanders, Miriam Bornhorst, Suzanne P MacFarland, Jo Lynne Rokita, Sharon J Diskin
Nature communications  ·  21 Nov 2025  ·  pubmed:41271695
Germline analysis of an international cohort of pediatric diffuse midline glioma patients.
Marion K Mateos, Pamela Ajuyah, Noemi Fuentes-Bolanos, Sam El-Kamand, Paulette Barahona, …, Sebastien Perreault, Chris Jones, Marie Wong-Erasmus, Mark J Cowley, David S Ziegler
Neuro-oncology  ·  08 Sep 2025  ·  pubmed:40072012
Kinome Reprogramming of G2/M Kinases and Repression of MYCN Contribute to Superior Efficacy of Lorlatinib in ALK-Driven Neuroblastoma.
Smita Matkar, Michael P East, Timothy J Stuhlmiller, Gabriela M Witek, Alvin Farrel, …, Jo Lynne Rokita, Mark Gerelus, John M Maris, Gary L Johnson, Yael P Mossé
Molecular cancer therapeutics  ·  02 Sep 2025  ·  pubmed:39907037
NRCAM variant defined by microexon skipping is a targetable cell surface proteoform in high-grade gliomas.
Priyanka Sehgal, Ammar S Naqvi, Makenna Higgins, Jiageng Liu, Kyra Harvey, …, Adam C Resnick, Hagen U Tilgner, Thomas De Raedt, Daniel J Powell, Andrei Thomas-Tikhonenko
Cell reports  ·  07 Aug 2025  ·  pubmed:40782352
Imaging Clusters of Pediatric Low-Grade Glioma Are Associated with Distinct Molecular Characteristics.
Anahita Fathi Kazerooni, Adam Kraya, Komal S Rathi, Meen Chul Kim, Varun Kesherwani, …, Sabine Mueller, Jo Lynne Rokita, Michael J Fisher, Adam C Resnick, Ali Nabavizadeh
AJNR. American journal of neuroradiology  ·  01 Aug 2025  ·  pubmed:39952665
Genetic ancestry superpopulations show distinct prevalence and outcomes across pediatric central nervous system tumors from the Pediatric Brain Tumor Atlas and Pediatric Neuro-Oncology Consortium.
Ryan J Corbett, Cricket C Gullickson, Zhuangzhuang Geng, Miguel A Brown, Bo Zhang, …, Angela J Waanders, Sebastian M Waszak, Sabine Mueller, Jo Lynne Rokita, Cassie Kline
Neuro-oncology  ·  21 Jun 2025  ·  pubmed:39847453
Germline Pathogenic DROSHA Variants Are Linked to Pineoblastoma and Wilms Tumor Predisposition.
Peter N Fiorica, Lisa Golmard, Jung Kim, Riyue Bao, Frank Y Lin, …, Douglas R Stewart, D Williams Parsons, Sharon E Plon, Kris Ann P Schultz, Kenan Onel
Clinical cancer research : an official journal of the American Association for Cancer Research  ·  14 Apr 2025  ·  pubmed:39992227
The Open Pediatric Cancer Project
Zhuangzhuang Geng, Eric Wafula, Ryan J Corbett, Yuanchao Zhang, Run Jin, …, Chuwei Zhong, Joseph M Dybas, Pei Wang, Deanne Taylor, Jo Lynne Rokita
GigaScience  ·  01 Jan 2025  ·  doi:10.1093/gigascience/giaf093
The Open Pediatric Cancer Project

2024

A proteogenomic surfaceome study identifies DLK1 as an immunotherapeutic target in neuroblastoma.
Amber K Hamilton, Alexander B Radaoui, Matthew Tsang, Daniel Martinez, Karina L Conkrite, …, Patrick H van Berkel, Malcolm A Smith, Benjamin A Garcia, John M Maris, Sharon J Diskin
Cancer cell  ·  24 Oct 2024  ·  pubmed:39454577
AutoGVP: a dockerized workflow integrating ClinVar and InterVar germline sequence variant classification.
Jung Kim, Ammar S Naqvi, Ryan J Corbett, Rebecca S Kaufman, Zalman Vaksman, …, Phillip B Storm, Adam C Resnick, Douglas R Stewart, Jo Lynne Rokita, Sharon J Diskin
Bioinformatics (Oxford, England)  ·  29 Feb 2024  ·  pubmed:38426335
AutoGVP
BARD1 germline variants induce haploinsufficiency and DNA repair defects in neuroblastoma.
Michael P Randall, Laura E Egolf, Zalman Vaksman, Minu Samanta, Matthew Tsang, …, Mehdi Layeghifard, Adam Shlien, John M Maris, Sharon J Diskin, Kristopher R Bosse
Journal of the National Cancer Institute  ·  10 Jan 2024  ·  pubmed:37688570

2023

Everolimus for Children With Recurrent or Progressive Low-Grade Glioma: Results From the Phase II PNOC001 Trial.
Daphne A Haas-Kogan, Mariam S Aboian, Jane E Minturn, Sarah E S Leary, Mohamed S Abdelbaki, …, Joanna J Phillips, Michael Prados, Annette M Molinaro, Sebastian M Waszak, Sabine Mueller
Journal of clinical oncology : official journal of the American Society of Clinical Oncology  ·  17 Nov 2023  ·  pubmed:37978951
Alternative lengthening of telomeres (ALT) in pediatric high-grade gliomas can occur without ATRX mutation and is enriched in patients with pathogenic germline mismatch repair (MMR) variants.
Jennifer L Stundon, Heba Ijaz, Krutika S Gaonkar, Rebecca S Kaufman, Run Jin, …, Suzanne P MacFarland, Douglas R Stewart, Sharon J Diskin, Jo Lynne Rokita, Kristina A Cole
Neuro-oncology  ·  06 Jul 2023  ·  pubmed:36541551
OpenPBTA: The Open Pediatric Brain Tumor Atlas.
Joshua A Shapiro, Krutika S Gaonkar, Stephanie J Spielman, Candace L Savonen, Chante J Bethell, …, Miguel A Brown, Adam C Resnick, Casey S Greene, Jo Lynne Rokita, Jaclyn N Taroni
Cell genomics  ·  31 May 2023  ·  pubmed:37492101
Identification of candidate genes for nicotine withdrawal in C57BL/6J × DBA/2J recombinant inbred mice
Maren L. Smith, Kristin M. Mignogna, Jo L. Rokita, Lorna MacLeod, M. Imad Damaj, Michael F. Miles
Genes, Brain and Behavior  ·  13 Feb 2023  ·  doi:10.1111/gbb.12844
Identification of candidate genes for nicotine withdrawal in C57BL/6J × DBA/2J recombinant inbred mice.
Maren L Smith, Kristin M Mignogna, Jo L Rokita, Lorna MacLeod, M Imad Damaj, Michael F Miles
Genes, brain, and behavior  ·  13 Feb 2023  ·  pubmed:36781202
Enhancing childhood cancer targetability.
Ammar S Naqvi, Jo Lynne Rokita
Nature cancer  ·  01 Feb 2023  ·  pubmed:36585448

2022

The children's brain tumor network (CBTN) - Accelerating research in pediatric central nervous system tumors through collaboration and open science.
Jena V Lilly, Jo Lynne Rokita, Jennifer L Mason, Tatiana Patton, Stephanie Stefankiewiz, …, Phillip B Storm, Rishi R Lulla, Michael Prados, Adam C Resnick, Angela J Waanders
Neoplasia (New York, N.Y.)  ·  03 Nov 2022  ·  pubmed:36335802
Upfront Biology-Guided Therapy in Diffuse Intrinsic Pontine Glioma: Therapeutic, Molecular, and Biomarker Outcomes from PNOC003.
Cassie Kline, Payal Jain, Lindsay Kilburn, Erin R Bonner, Nalin Gupta, …, Michael Prados, Adam Resnick, Sebastian M Waszak, Javad Nazarian, Sabine Mueller
Clinical cancer research : an official journal of the American Association for Cancer Research  ·  15 Sep 2022  ·  pubmed:35852795
Development of GPC2-directed chimeric antigen receptors using mRNA for pediatric brain tumors.
Jessica B Foster, Crystal Griffin, Jo Lynne Rokita, Allison Stern, Cameron Brimley, …, Phillip B Storm, David M Barrett, Adam C Resnick, John M Maris, Kristopher R Bosse
Journal for immunotherapy of cancer  ·  01 Sep 2022  ·  pubmed:36167467

2021

Macrophages in SHH subgroup medulloblastoma display dynamic heterogeneity that varies with treatment modality.
Mai T Dang, Michael V Gonzalez, Krutika S Gaonkar, Komal S Rathi, Patricia Young, …, Candace Savonen, Fernanda Mafra, Hakon Hakonarson, Tom Curran, Malay Haldar
Cell reports  ·  30 Mar 2021  ·  pubmed:33789113
GAS7 Deficiency Promotes Metastasis in MYCN-Driven Neuroblastoma.
Zhiwei Dong, Kok Siong Yeo, Gonzalo Lopez, Cheng Zhang, Erin N Dankert Eggum, …, Jan M van Deursen, Hu Li, Jennifer J Westendorf, John M Maris, Shizhen Zhu
Cancer research  ·  18 Feb 2021  ·  pubmed:33602789

2020

annoFuse: an R Package to annotate, prioritize, and interactively explore putative oncogenic RNA fusions.
Krutika S Gaonkar, Federico Marini, Komal S Rathi, Payal Jain, Yuankun Zhu, …, Pichai Raman, Adam C Resnick, Konstantin Strauch, Jaclyn N Taroni, Jo Lynne Rokita
BMC bioinformatics  ·  14 Dec 2020  ·  pubmed:33317447
Integrated Proteogenomic Characterization across Major Histological Types of Pediatric Brain Cancer.
Francesca Petralia, Nicole Tignor, Boris Reva, Mateusz Koptyra, Shrabanti Chowdhury, …, Amanda G Paulovich, Adam C Resnick, Phillip B Storm, Brian R Rood, Pei Wang
Cell  ·  25 Nov 2020  ·  pubmed:33242424
A transcriptome-based classifier to determine molecular subtypes in medulloblastoma.
Komal S Rathi, Sherjeel Arif, Mateusz Koptyra, Ammar S Naqvi, Deanne M Taylor, Phillip B Storm, Adam C Resnick, Jo Lynne Rokita, Pichai Raman
PLoS computational biology  ·  29 Oct 2020  ·  pubmed:33119584
LIN28B promotes neuroblastoma metastasis and regulates PDZ binding kinase.
Dongdong Chen, Julie Cox, Jayabhargav Annam, Melanie Weingart, Grace Essien, …, Daisy Li, Cara Shields, Oskar Laur, John M Maris, Robert W Schnepp
Neoplasia (New York, N.Y.)  ·  24 Apr 2020  ·  pubmed:32339949
Limited antitumor activity of combined BET and MEK inhibition in neuroblastoma.
Jason R Healy, Lori S Hart, Alexander L Shazad, Maria E Gagliardi, Matthew Tsang, …, Olena Barbash, Vandana Batra, Minu Samanta, John M Maris, Robert W Schnepp
Pediatric blood & cancer  ·  19 Apr 2020  ·  pubmed:32307821
Epigenomic profiling of neuroblastoma cell lines.
Kristen Upton, Apexa Modi, Khushbu Patel, Nathan M Kendsersky, Karina L Conkrite, …, Gregory I Sacks, Paolo Fortina, Sharon J Diskin, John M Maris, Jo Lynne Rokita
Scientific data  ·  14 Apr 2020  ·  pubmed:32286315
Telomere Maintenance Mechanisms Define Clinical Outcome in High-Risk Neuroblastoma.
Balakrishna Koneru, Gonzalo Lopez, Ahsan Farooqi, Karina L Conkrite, Thinh H Nguyen, …, Shengping Yang, David A Wheeler, John M Maris, Sharon J Diskin, C Patrick Reynolds
Cancer research  ·  14 Apr 2020  ·  pubmed:32291317
CAMKV Is a Candidate Immunotherapeutic Target in
Robyn T Sussman, Jo Lynne Rokita, Kevin Huang, Pichai Raman, Komal S Rathi, …, Maria Lane, Lori S Hart, Tricia Bhatti, Bruce Pawel, John M Maris
Frontiers in oncology  ·  06 Mar 2020  ·  pubmed:32211329
Pediatric high-grade glioma resources from the Children's Brain Tumor Tissue Consortium.
Heba Ijaz, Mateusz Koptyra, Krutika S Gaonkar, Jo Lynne Rokita, Valerie P Baubet, …, Maria Rita Santi, Phillip B Storm, Adam Resnick, Angela J Waanders, Kristina A Cole
Neuro-oncology  ·  11 Jan 2020  ·  pubmed:31613963

2019

ASCL1 is a MYCN- and LMO1-dependent member of the adrenergic neuroblastoma core regulatory circuitry.
Lu Wang, Tze King Tan, Adam D Durbin, Mark W Zimmerman, Brian J Abraham, …, Jo Lynne Rokita, John M Maris, Richard A Young, A Thomas Look, Takaomi Sanda
Nature communications  ·  09 Dec 2019  ·  pubmed:31819055
Combined innate and adaptive immunotherapy overcomes resistance of immunologically cold syngeneic murine neuroblastoma to checkpoint inhibition.
Julie Voeller, Amy K Erbe, Jacob Slowinski, Kayla Rasmussen, Peter M Carlson, …, John Maris, Jacquelyn A Hank, Zachary S Morris, Alexander L Rakhmilevich, Paul M Sondel
Journal for immunotherapy of cancer  ·  06 Dec 2019  ·  pubmed:31810498
Genomic Profiling of Childhood Tumor Patient-Derived Xenograft Models to Enable Rational Clinical Trial Design.
Jo Lynne Rokita, Komal S Rathi, Maria F Cardenas, Kristen A Upton, Joy Jayaseelan, …, Malcolm A Smith, Richard B Lock, Pichai Raman, David A Wheeler, John M Maris
Cell reports  ·  05 Nov 2019  ·  pubmed:31693904
YAP1 Mediates Resistance to MEK1/2 Inhibition in Neuroblastomas with Hyperactivated RAS Signaling.
Grace E Coggins, Alvin Farrel, Komal S Rathi, Colin M Hayes, Laura Scolaro, Jo Lynne Rokita, John M Maris
Cancer research  ·  31 Oct 2019  ·  pubmed:31672841
Germline 16p11.2 Microdeletion Predisposes to Neuroblastoma.
Laura E Egolf, Zalman Vaksman, Gonzalo Lopez, Jo Lynne Rokita, Apexa Modi, Patricia V Basta, Hakon Hakonarson, Andrew F Olshan, Sharon J Diskin
American journal of human genetics  ·  29 Aug 2019  ·  pubmed:31474320
The Pediatric Cell Atlas: Defining the Growth Phase of Human Development at Single-Cell Resolution.
Deanne M Taylor, Bruce J Aronow, Kai Tan, Kathrin Bernt, Nathan Salomonis, …, Yi Xing, Sek Won Kong, Carsten G Bönnemann, Kenneth D Mandl, Peter S White
Developmental cell  ·  28 Mar 2019  ·  pubmed:30930166

2018

Cross-Cohort Analysis Identifies a TEAD4-MYCN Positive Feedback Loop as the Core Regulatory Element of High-Risk Neuroblastoma.
Presha Rajbhandari, Gonzalo Lopez, Claudia Capdevila, Beatrice Salvatori, Jiyang Yu, …, Antonio Iavarone, Anna Lasorella, Jose M Silva, John M Maris, Andrea Califano
Cancer discovery  ·  06 Mar 2018  ·  pubmed:29510988

2017

Identification of GPC2 as an Oncoprotein and Candidate Immunotherapeutic Target in High-Risk Neuroblastoma.
Kristopher R Bosse, Pichai Raman, Zhongyu Zhu, Maria Lane, Daniel Martinez, …, Marco A Marra, Michael D Taylor, Dimiter S Dimitrov, Crystal L Mackall, John M Maris
Cancer cell  ·  11 Sep 2017  ·  pubmed:28898695
Transcriptomic profiling of 39 commonly-used neuroblastoma cell lines.
Jo Lynne Harenza, Maura A Diamond, Rebecca N Adams, Michael M Song, Heather L Davidson, Lori S Hart, Maiah H Dent, Paolo Fortina, C Patrick Reynolds, John M Maris
Scientific data  ·  28 Mar 2017  ·  pubmed:28350380

2016

International Comparison of Enumeration-Based Quantification of DNA Copy-Concentration Using Flow Cytometric Counting and Digital Polymerase Chain Reaction.
Hee-Bong Yoo, Sang-Ryoul Park, Lianhua Dong, Jing Wang, Zhiwei Sui, …, Jim F Huggett, Helen Parkes, Margaret C Kline, Jo Lynne Harenza, Peter M Vallone
Analytical chemistry  ·  30 Nov 2016  ·  pubmed:28193036
Identification of quantitative trait loci and candidate genes for an anxiolytic‐like response to ethanol inBXDrecombinant inbred strains
A. H. Putman, A. R. Wolen, J. L. Harenza, R. K. Yordanova, B. T. Webb, E. J. Chesler, M. F. Miles
Genes, Brain and Behavior  ·  01 Apr 2016  ·  doi:10.1111/gbb.12289

2015

Inhibition of monoacylglycerol lipase reduces nicotine withdrawal
P P Muldoon, J Chen, J L Harenza, R A Abdullah, L J Sim‐Selley, B F Cravatt, M F Miles, X Chen, A H Lichtman, M I Damaj
British Journal of Pharmacology  ·  08 Jan 2015  ·  doi:10.1111/bph.12948

2014

The α3β4* nicotinicAChreceptor subtype mediates physical dependence to morphine: mouse and human studies
P P Muldoon, K J Jackson, E Perez, J L Harenza, S Molas, …, M Dierssen, M F Miles, X Chen, M De Biasi, M I Damaj
British Journal of Pharmacology  ·  25 Jul 2014  ·  doi:10.1111/bph.12741

2013

Genetic variation within theChrna7gene modulates nicotine reward‐like phenotypes in mice
J. L. Harenza, P. P. Muldoon, M. De Biasi, M. I. Damaj, M. F. Miles
Genes, Brain and Behavior  ·  26 Dec 2013  ·  doi:10.1111/gbb.12113

2011

The Neuropeptide Galanin and Variants in the GalR1 Gene are Associated with Nicotine Dependence
Kia J Jackson, Xiangning Chen, Michael F Miles, JoLynne Harenza, M Imad Damaj
Neuropsychopharmacology  ·  27 Jul 2011  ·  doi:10.1038/npp.2011.123
Genetic analysis of the neurosteroid deoxycorticosterone and its relation to alcohol phenotypes: identification of QTLs and downstream gene regulation.
Patrizia Porcu, Todd K O’Buckley, Soomin C Song, Jo Lynne Harenza, Lu Lu, Xusheng Wang, Robert W Williams, Michael F Miles, A Leslie Morrow
PloS one  ·  08 Apr 2011  ·  pubmed:21494628

Grid of blog posts

2026

Dr. Goswami wins first place abstract at the CHARM symposium
Dr. Goswami wins first place abstract at the CHARM symposium

CONGRATULATIONS to our Staff Scientist, Dr. Meghali Goswami, for winning first place abstract and giving a lightning talk at the CHARM symposium, the 4th Annual Cell and Gene Therapy Symposium in the Mid-Atlantic Region! 🏆

TAPESTRY preprint is online
TAPESTRY preprint is online!

We are excited to share our preprint, “TAPESTRY: an interactive resource for exploring tumor-enriched splice junctions in pediatric brain tumors,” now on arXiv! This work was spearheaded by Dr. Patricia Sullivan, with underlying data generated by Dr. Ryan Corbett and infrastructure support by Dr. Chao Di.

Rokita Lab shines at the GW Bioinformatics Symposium
Rokita Lab shines at the GW Bioinformatics Symposium

What a day at the GW Bioinformatics Symposium! 🎉

Dr. Rokita begins mentoring postdocs at CHOP
Dr. Rokita begins mentoring postdocs at CHOP

Dr. Rokita has started volunteering as a postdoctoral mentor through the Children’s Hospital of Philadelphia (CHOP) mentoring program! As a former CHOP postdoc herself, she is excited to give back by supporting the next generation of researchers at the institution where she spent nearly a decade of her career.

Introducing OpenPedCanExpress
Introducing OpenPedCanExpress

We are excited to share OpenPedCanExpress, a new web tool for exploring gene expression across pediatric tumors and normal tissue controls! Search any gene and instantly compare its expression in pediatric brain tumors against normal brain tissue, all in your browser with no code required.

Dr. Rokita joins the PBTF Technology Advisory Network
Dr. Rokita joins the PBTF Technology Advisory Network

Dr. Rokita has joined the Pediatric Brain Tumor Foundation (PBTF) Technology Advisory Network (TAN)!

Remembering John Matthew for Childhood Cancer Awareness Month
Remembering John Matthew for Childhood Cancer Awareness Month

On this last day of Childhood Cancer Awareness Month, I’m remembering my little cousin, John Matthew Dean. John Matthew was born on November 21, 1993, and passed away in August of 1998 after a battle with a malignant brain tumor. He was four years old.

Rokita Lab returns to AACR Pediatrics
Rokita Lab returns to AACR Pediatrics

So proud of Dr. Ryan Corbett and Dr. Meg Goswami, who represented the Rokita Lab at the 2026 American Association for Cancer Research (AACR) Pediatric Cancer Conference! 🎉

Dylan Mach joins the Rokita Lab
Dylan Mach joins the Rokita Lab!

We are excited to welcome Dylan Mach, a second-year undergraduate student at The George Washington University, to the Rokita Lab 🎉. Dylan is majoring in Biology and minoring in Statistics, and is part of GWU’s Seven-Year BA/MD program.

Our very first Rokita Lab retreat
Our very first Rokita Lab retreat!

So grateful for 1.5 days of dedicated Rokita Lab time this week with our amazing scientist team — Dr. Ryan Corbett, Dr. Patricia Sullivan, Dr. Meg Goswami, and Dr. Chao Di.

Congratulations to Deborah on a successful METEOR summer internship
Congratulations to Deborah on a successful METEOR summer internship!

Congratulations to Deborah Torrico-Pardo on wrapping up a successful summer internship in the Rokita Lab, mentored by Dr. Meg Goswami!

A great day at the CCIR Retreat
A great day at the CCIR Retreat

It was great to be back at Children’s National Hospital for the annual Center for Cancer and Immunology Research (CCIR) Retreat!

BTI Bioinformatics Core dedicates a retreat to engineering and automation
BTI Bioinformatics Core dedicates a retreat to engineering and automation

While part of the team was on the other side of the world at ISPNO, Bailey, Rehman, Alex, and Aylar spent a day and a half at a focused Bioinformatics Operations retreat, dedicated entirely to engineering and automation.

Rokita Lab science on display at ISPNO in Sydney
Rokita Lab science on display at ISPNO in Sydney

The Rokita Lab traveled to Sydney this week for the International Symposium on Pediatric Neuro-Oncology (ISPNO), where we shared our latest work with the global pediatric neuro-oncology community.

Deborah Torrico-Pardo joins the Rokita Lab
Deborah Torrico-Pardo joins the Rokita Lab!

We are excited to welcome high school summer student, Deborah Torrico-Pardo, to the Rokita Lab at Children’s National Hospital (CNH) 🎉. Deborah was selected through the prestigious METEOR Summer Program at Children’s National Hospital and will work on preclinical validation of a tumor-enriched splice event in pediatric brain tumors.

Dr. Kaylyn Clark selected to participate in TEAMS program
Dr. Kaylyn Clark selected to participate in TEAMS program!

Congratulations to Dr. Kaylyn Clark on being selected for the TEAMS training program.

Representing the Rokita and Gilbert Labs at the GWU Cancer Center retreat
Representing the Rokita and Gilbert Labs at the GWU Cancer Center retreat

Proud to see Jacob White, Dr. Kaylyn Clark, and Dr. Meg Goswami represent the Rokita and Gilbert Labs at this year’s George Washington University Cancer Center retreat!

Dr. Patricia Sullivan awarded an ALSF Young Investigator Award
Dr. Patricia Sullivan awarded an ALSF Young Investigator Award!

Congratulations to Dr. Patricia Sullivan on being awarded a prestigious Young Investigator Grant from Alex’s Lemonade Stand Foundation (ALSF)!

Jacob White awarded a St. Baldrick s Summer Fellowship
Jacob White awarded a St. Baldrick's Summer Fellowship!

Congratulations to Jacob White for being awarded a summer fellowship from St. Baldrick’s Foundation! Jacob’s project “Association of genetic ancestry with pediatric CNS tumor splicing” will support the lab’s pediatric brain tumor research by identifying genetic determinants of alternative splicing and their contributions to disease.

Dr. Rehman Qureshi joins the Brain Tumor Institute Bioinformatics Core as Assistant Director
Dr. Rehman Qureshi joins the Brain Tumor Institute Bioinformatics Core as Assistant Director!

We are thrilled to welcome Dr. Rehman Qureshi as Assistant Director of the Brain Tumor Institute Bioinformatics Core at Children’s National Hospital (CNH) 🎉.

A strong showing at Children s National Research, Education, and Innovation week
A strong showing at Children's National Research, Education, and Innovation week!

Congratulations to Children’s National Hospital on another outstanding Research, Education, and Innovation (REI) week!

Vinay Gujjula awarded an ALSF POST Award
Vinay Gujjula awarded an ALSF POST Award!

Congratulations to Vinay Gujjula for being awarded a Pediatric Oncology Student Training (POST) Award from Alex’s Lemonade Stand Foundation (ALSF). Vinay’s project “Investigating the association of genetic ancestry with pathogenic variation in pediatric patients with brain tumors” will support the lab’s germline variant analysis and broader pediatric brain tumor research through ancestry-informed computational analyses of large pediatric cancer datasets.

Our study of RNA splicing across pediatric brain tumors is now published in Neuro-Oncology Pediatrics!

We are excited to share the publication of our latest study, “Alternative splicing in pediatric central nervous system tumors highlights oncofetal candidate CLK1 exon 4,” now published in Neuro-Oncology Pediatrics. Led by co-first authors Dr. Ammar Naqvi and Dr. Patricia Sullivan, this work represents years of collaborative effort across institutions and builds on our ongoing mission to understand the molecular programs that shape pediatric brain tumors.

Bailey Farrow joins the BTI Bioinformatics Core Leadership
Bailey Farrow joins the BTI Bioinformatics Core Leadership!

We are thrilled to welcome Bailey Farrow to Children’s National Hospital (CNH) as our new Senior Bioinformatics Program and Operations Manager for the Brain Tumor Institute (BTI) Bioinformatics Core! 🎉

Jacob White joins the Rokita Lab
Jacob White joins the Rokita Lab!

We are excited to welcome masters student, Jacob White, to the Rokita Lab at Children’s National Hospital (CNH) 🎉. Jacob will begin his research by studying both mechanisms of RNA splicing in pediatric brain tumors and identifying tractable splice-derived therapeutic targets.

Vinay Gujjula joins the Rokita Lab
Vinay Gujjula joins the Rokita Lab!

We are excited to welcome masters student, Vinay Gujjula, to the Rokita Lab at Children’s National Hospital (CNH) 🎉. Vinay will begin his research by investigating the inheritance of pathogenic or likely pathogenic germline variants in pediatric brain tumors.

2025

Our integrative analysis of PBTA host-tumor genomes has been published in Nature Communications!

We’re thrilled to share the publication of our latest study, “Germline pathogenic variation impacts somatic alterations and patient outcomes in pediatric central nervous system tumors,” now out in Nature Communications. Led by Dr. Ryan Corbett in the Rokita Lab, this work represents a comprehensive multi-omic analysis of germline and somatic data from 830 pediatric brain tumor patients in the #PBTA — truly a tour de force by the team.

Dr. Meghali Goswami joins the Rokita Lab
Dr. Meghali Goswami joins the Rokita Lab!

We are excited to welcome Dr. Meghali (Meg) Goswami as a Staff Scientist in the Rokita Lab at Children’s National Hospital (CNH) 🎉. Meg joins us from the National Cancer Institute, where she became a leading expert in tumor immunology, translational research, and biomarker discovery for immuno-oncology therapies.

Dr. Shang-Yang Sam Chen joins the Brain Tumor Institute Bioinformatics Core
Dr. Shang-Yang (Sam) Chen joins the Brain Tumor Institute Bioinformatics Core!

We are excited to welcome Dr. Shang-Yang (Sam) Chen as a Bioinformatics Scientist in the Brain Tumor Institute Bioinformatics Core at Children’s National Hospital (CNH) 🎉.

Representing the Rokita Lab at AACR Pediatrics
Representing the Rokita Lab at AACR Pediatrics

Grateful and proud of Ryan Corbett and Dr. Patricia Sullivan for attending the American Association for Cancer Research (AACR) Pediatric Cancer Conference on behalf of the Rokita Lab, in our very first year as a lab!

From Foundation to Future: Dr. Rokita presents the first year of the BTI Bioinformatics Core
From Foundation to Future: Dr. Rokita presents the first year of the BTI Bioinformatics Core

At this year’s Center for Cancer and Immunology Research (CCIR) Retreat, Dr. Rokita gave a talk, entitled, “From Foundation to Future: The First Year of the BTI Bioinformatics Core.”

Dr. Corbett named as 2025 CCF NextGen Awardee
Dr. Corbett named as 2025 CCF NextGen Awardee!

We are thrilled to announce that Dr. Ryan Corbett has been selected as the 2025 NextGen Awardee by the Children’s Cancer Foundation for his grant entitled, “Identification and functional targeting of alternative splice site usage in pediatric high-grade gliomas”.

Akhil Chada joins the Rokita Lab
Akhil Chada joins the Rokita Lab!

We are excited to welcome Akhil Chada to the Rokita Lab at Children’s National Hospital (CNH) 🎉. Akhil joins us as a summer student and rising high school senior at James Madison High School in Fairfax County, Virginia. He brings expertise in several coding languages (Python, C++, R, and Java) and advanced mathematics.

The Open Pediatric Cancer manuscript has been accepted for publication!

We are excited to announce that our large, collaborative work on the Open Pediatric Cancer (OpenPedCan) Project has been accepted in GigaScience! We are very grateful for the many researchers, clinicians, engineers, bioinformaticians, and investigators who have contributed to this work – a true team effort! Read the preprint here.

New collaborative manuscript identifying and testing a splice event in the NRCAM gene has been accepted in Cell Reports!

We were thrilled to contribute to the recently accepted manuscript, “NRCAM variant defined by microexon skipping is an essential, antigenically distinct, and targetable surface proteoform in high-grade gliomas”, led by the lab of collaborator Dr. Andrei Thomas-Tikhonenko. In this project, we identified a tumor-specific exon inclusion event in the NRCAM gene as a new therapeutic target. Read the preprint here.

Aylar Babaei joins the BTI Bioinformatics Core
Aylar Babaei joins the BTI Bioinformatics Core!

We are thrilled to announce Aylar Babaei as a Bioinformatics Scientist in the BTI Bioinformatics Core at Children’s National Hospital (CNH) 🎉. Aylar joins the Core after a productive year right here at CNH, where she contributed to multiple computational workflows, including Ribo-seq analysis, HLA typing, and MHC class I epitope prediction. She brings hands-on experience running large-scale pipelines on the high-performance computing (HPC) environment.

Dr. Chao Di joins the Rokita Lab and Brain Tumor Institute Bioinformatics Core
Dr. Chao Di joins the Rokita Lab and Brain Tumor Institute Bioinformatics Core!

We are excited to welcome Dr. Chao Di as a Senior Bioinformatics Engineer and Scientist in the Rokita Lab and the Brain Tumor Institute Bioinformatics Core at Children’s National Hospital (CNH) 🎉.

Dr. Patricia Sullivan joins the Rokita Lab
Dr. Patricia Sullivan joins the Rokita Lab!

We are excited to announce the arrival of Dr. Patricia Sullivan as a Bioinformatics Scientist in the Rokita Lab at Children’s National Hospital (CNH) 🎉. Patricia joins us from the Children’s Cancer Institute in Sydney, where she became a leading expert in splice-altering variation in pediatric cancer and rare disease genomics.

Dr. Jessica Daggett joins the Brain Tumor Institute Bioinformatics Core
Dr. Jessica Daggett joins the Brain Tumor Institute Bioinformatics Core!

We are happy to announce our recruitment of Dr. Jessica Daggett as a Bioinformatics Scientist in the Brain Tumor Institute (BTI) Bioinformatics Core at Children’s National Hospital (CNH) 🎉.

Dr. Kaylyn Clark joins the Rokita Lab and Brain Tumor Institute
Dr. Kaylyn Clark joins the Rokita Lab and Brain Tumor Institute!

We are happy to announce our recruitment of Dr. Kaylyn Clark as a Postdoctoral Fellow in the Rokita Lab and Brain Tumor Institute (BTI) at Children’s National Hospital (CNH) 🎉.

New collaborative manuscript exploring germline pathogenic variation in pediatric DMGs published!

We were thrilled to contribute to the recent publication, “Germline analysis of an international cohort of pediatric diffuse midline glioma patients”, led by collaborator Dr. Marion Mateos. In this project, we assessed pathogenicity of germline variants driving DIPG and DMG. Read more about it here.

Dr. Bicna Song joins the Brain Tumor Institute Bioinformatics Core
Dr. Bicna Song joins the Brain Tumor Institute Bioinformatics Core!

We are happy to announce our recruitment of Dr. Bicna Song as a Bioinformatics Scientist in the Brain Tumor Institute (BTI) Bioinformatics Core at Children’s National Hospital (CNH) 🎉.

New press release - Q A with Dr. Rokita: Building Bioinformatics Infrastructure at the Brain Tumor Institute
New press release - Q&A with Dr. Rokita: Building Bioinformatics Infrastructure at the Brain Tumor Institute

Dr. Rokita recently sat down with the press team at Children’s National to discuss her laboratory’s research, the development of the Brain Tumor Institute (BTI) Bioinformatics Core, and her collaborative and open science vision for the future. Read all about it here!

New tumor predisposition syndrome described!

We are happy to announce the publication of “Germline pathogenic DROSHA variants are linked to pineoblastoma and Wilms tumor predisposition”, an international collaboration in which we describe a new tumor syndrome characterized by pathogenic germline DROSHA variants. Read more about it here.

Alex Sickler joins the Rokita Lab
Alex Sickler joins the Rokita Lab!

We are thrilled to welcome Alex Sickler as a Bioinformatics Engineer in the Rokita Lab and Brain Tumor Institute (BTI) Bioinformatics Core at Children’s National Hospital (CNH) 🎉. Alex joins us after many productive years of bioinformatics engineering and infrastructure management work at GeneDx, the National Cancer Institute, and the Children’s Hospital of Philadelphia (CHOP).

Manuscript describing molecular features of low-grade glioma imaging clusters published!

We were thrilled to be a part of the recent publication, “Imaging Clusters of Pediatric Low-Grade Glioma are Associated with Distinct Molecular Characteristics”, led by our collaborator Dr. Anahita Fathi Kazerooni. Read more about it here.

Germline manuscript is online at medRxiv!

Our latest manuscript, “Germline pathogenic variation impacts somatic alterations and patient outcomes in pediatric CNS tumors”, work led by Dr. Ryan Corbett, is now preprinted on MedRxiv!

Kinome reprogramming in neuroblastoma manuscript published!

From Dr. Yael Mosse’s laboratory, we are happy to see the work of Dr. Smita Matkar, “Kinome reprogramming of G2/M kinases and repression of MYCN contribute to superior efficacy of lorlatinib in ALK-driven neuroblastoma”, published today. We were happy to have played a small role in this work! Read more about it here.

Preprint describing NRCAM, a new pediatric high-grade glioma neoepitope online!

As a part of our splice-derived neoepitope identification research, we partnered with Dr. Andrei Thomas-Tikhonenko’s laboratory at Children’s Hospital of Philadelphia in which they validated an NRCAM splice event as a targetable immunotherapeutic target for pediatric high-grade gliomas. Please read more in “Neuronal cell adhesion molecule (NRCAM) variant defined by microexon skipping is an essential, antigenically distinct, and targetable proteoform in high-grade glioma” here.

Dr. Ryan Corbett joins the Rokita Lab
Dr. Ryan Corbett joins the Rokita Lab!

We are thrilled to welcome Dr. Ryan Corbett as a Senior Bioinformatics Scientist in the Rokita Lab at Children’s National Hospital (CNH) 🎉. Ryan joins us after two years of outstanding work under the mentorship of Dr. Rokita at the Children’s Hospital of Philadelphia (CHOP).

2024

Genetic ancestry manuscript accepted at NeuroOncology!

Our newest manuscript, “Genetic ancestry superpopulations show distinct prevalence and outcomes across pediatric central nervous system tumors from the PBTA and PNOC”, work led by Dr. Ryan Corbett, has been accepted in NeuroOncology!

Rokita Lab opens at Children's National Hospital

We are thrilled to announce the opening of the Rokita Lab at Children’s National within the Brain Tumor Institute (BTI) and Center for Cancer and Immunology Research (CCIR)! Situated in a leading pediatric institution, our lab is equipped with cutting-edge technology and resources, fostering a collaborative environment for groundbreaking discoveries. We’re excited to accelerate our research and expand our efforts to improve outcomes for children with brain cancer.

Cols

Text

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Nulla facilisi etiam dignissim diam quis. Id aliquet lectus proin nibh nisl condimentum id venenatis a.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Nulla facilisi etiam dignissim diam quis. Id aliquet lectus proin nibh nisl condimentum id venenatis a. Tristique magna sit amet purus gravida quis blandit turpis cursus. Ultrices eros in cursus turpis massa tincidunt dui ut ornare. A cras semper auctor neque vitae tempus quam pellentesque nec. At tellus at urna condimentum mattis pellentesque. Ipsum consequat nisl vel pretium. Ultrices mi tempus imperdiet nulla malesuada pellentesque elit eget gravida. Integer vitae justo eget magna fermentum iaculis eu non diam. Mus mauris vitae ultricies leo integer malesuada nunc vel. Leo integer malesuada nunc vel risus. Ornare arcu odio ut sem nulla pharetra. Purus semper eget duis at tellus at urna condimentum. Enim neque volutpat ac tincidunt vitae semper quis lectus.

Images

Fig. 1a
Fig. 1a

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Fig. 1b
Fig. 1b

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Fig. 1c
Fig. 1c

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Code

const test = "Lorem ipsum dolor sit amet";
const test = "Lorem ipsum dolor sit amet";
const test = "Lorem ipsum dolor sit amet";